Rocuronium concentration of cell saver blood following cardiac surgery

Rocuronium concentration of cell saver blood following cardiac surgery - Rocuronium concentration of cell saver blood following cardiac surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040877

Enrollment

Registered

2020-06-24

Start date

2020-06-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

single heart valve repair or replacement or similar non-invasive cardiac surgery

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient who is receiving single heart valve repair or replacement or similar relatively low invasive cardiac surgery use of cell saver during cardiac surgery

Exclusion criteria

Exclusion criteria: patient who is allergic to muscle relaxants

Design outcomes

Primary

Measure	Time frame
Rocuronium concentration of cell saver blood	—

Countries

Japan

Contacts

Public ContactHajime Iwasaki

Nihon University School of Medicine Department of Anesthesiology

iwasaki.hajime@nihon-u.ac.jp+81-3-3972-8111

Outcome results